Recent Posts
- Sarcomatrix Applies SarcoVista™ Translational Modeling to First-in-Human Dose Selection for S-969
- Women Founders Still Lead Nearly One in Four PurposeBuilt100™ Companies
- Sarcomatrix Therapeutics Opens Accredited Investor Round for Once-Daily Pill Designed to Address Duchenne Regardless of Genetic Mutation
- Watershed Medical Successfully Closes $4.2 Million Capital Raise
- IllumiCell AI Successfully Completes Regulation Crowdfunding Capital Raise
Recent Comments
No comments to show.